Distal symmetric polyneuropathy (DSP) related to human immunodeficiency virus (HIV) is
one of the most common neurologic complications of HIV, possibly affecting as many as …

Hyperlipidaemia, particularly hypertriglyceridemia, is associated with the development and
progression of neuropathy. Lipid modifying agents may represent a potential therapeutic …

Objectives: To estimate neuropathic sign/symptom rates with initiation of combination
antiretroviral therapy (cART) in HIV-infected ART-naive patients, and to investigate risk …

HIV-associated sensory neuropathy is the most frequent manifestation of HIV disease,
afflicting 40–50% of patients whose HIV disease is otherwise controlled by antiretroviral …

HIV-associated sensory neuropathy (HIV-SN) is a frequent complication of HIV infection and
a major source of morbidity. A cross-sectional deep profiling study examining HIV-SN was …

Chronic pain remains a prevalent and disabling problem for people living with HIV in the
current antiretroviral treatment era. Psychosocial treatments may have promise for managing …

Peripheral nerve disorders are associated with all stages of HIV infection. Distal sensory
polyneuropathy is characterised by often-disabling pain that is difficult to treat. It is prevalent …

The prevalence of those affected by HIV-DSP will continue to grow with the aging population
of HIV-infected individuals. Compared to the diabetic neuropathy drug trials, trials in both …

Peripheral neuropathy (PN) is a common neurological complication of HIV infection that has
debilitating effects on quality of life. While there has been a comprehensive evaluation of the …

2.1. Study design CNS HIV Anti-Retroviral Therapy Effects Research (CHARTER) is a
prospective, cross-sectional and longitudinal, observational cohort study designed to …